SEC Comment Letter 0000000000-23-012507 to Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Cyclo Therapeutics, Inc. (CYTH, CYTHW) (CIK 0000922247)
Date: Nov. 15, 2023 · CIK: 0000922247 · Accession: 0000000000-23-012507
AI Filing Summary & Sentiment
File numbers found in text: 333-275371
Letter
United States securities and exchange commission logo November 15, 2023 Joshua Fine Chief Financial Officer Cyclo Therapeutics, Inc. 6714 NW 16th Street, Suite B Gainesville, FL 32653 Re:Cyclo Therapeutics, Inc. Registration Statement on Form S-4 Filed November 7, 2023 File No. 333-275371 Dear Joshua Fine: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Alison Newman
Show Raw Text
United States securities and exchange commission logo
November 15, 2023
Joshua Fine
Chief Financial Officer
Cyclo Therapeutics, Inc.
6714 NW 16th Street, Suite B
Gainesville, FL 32653
Re:Cyclo Therapeutics, Inc.
Registration Statement on Form S-4
Filed November 7, 2023
File No. 333-275371
Dear Joshua Fine:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Alison Newman